Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Dec;17(12):1318.
doi: 10.1016/S1473-3099(17)30305-5.

A travelling camper with a spiking fever, headache, myalgia, hepatitis, and intracellular inclusions

Jens Vikse  1 , Jan Klos  2 , Aase Berg  3
Affiliations
Case Reports

A travelling camper with a spiking fever, headache, myalgia, hepatitis, and intracellular inclusions

Jens Vikse et al. Lancet Infect Dis. 2017 Dec.
No abstract available

PubMed Disclaimer

Figures

Figure 154-1
Figure 154-1
Influenza replication and site of action of antiviral agents. IMPD, inosine monophosphate dehydrogenase; NEP, nuclear export protein; NP, nucleoprotein; P, polymerase; RNP, ribonuclear protein; siRNA, small inhibitory ribonucleic acid.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

Key References

    1. Aoki F.Y., Sitar D.S. Clinical pharmacokinetics of amantadine hydrochloride. Clin Pharmacokinet. 1988;14:35–51. - PubMed
    1. Duval X., van der Werf S., Blanchon T. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med. 2010;7:e1000362. - PMC - PubMed
    1. Fiore A.E., Fry A., Shay D. Antiviral agents for the treatment and chemoprophylaxis of influenza – recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep/CDC. 2011;60:1–24. - PubMed
    1. Hayden F.G. Advances in antivirals for non-influenza respiratory virus infections. Influenza Other Respir Viruses. 2013;7(Suppl. 3):36–43. - PMC - PubMed
    1. Ison M.G., Szakaly P., Shapira M.Y. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients. Antivir Ther. 2012;17:955–964. - PubMed

References

    1. Hayden F.G. Advances in antivirals for non-influenza respiratory virus infections. Influenza Other Respir Viruses. 2013;7(Suppl. 3):36–43. - PMC - PubMed
    1. Chan J.F., Chan K.H., Kao R.Y. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect. 2013;67:606–616. - PMC - PubMed
    1. de Wilde A.H., Jochmans D., Posthuma C.C. Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture. Antimicrob Agents Chemother. 2014;58:4875–4884. - PMC - PubMed
    1. Hayden F.G. Newer influenza antivirals, biotherapeutics and combinations. Influenza Other Respir Viruses. 2013;7(Suppl.1):63–75. - PMC - PubMed
    1. Geevarghese B., Simoes E.A. Antibodies for prevention and treatment of respiratory syncytial virus infections in children. Antivir Ther. 2012;17:201–211. - PubMed

Publication types

MeSH terms